A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
Public ClinicalTrials.gov record NCT01412060. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to evaluate the efficacy and safety of cariprazine relative to placebo in the prevention of relapse of symptoms in participants with schizophrenia.
Study identification
- NCT ID
- NCT01412060
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 765 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 26, 2011
- Primary completion
- Sep 2, 2014
- Completion
- Sep 2, 2014
- Last update posted
- Jul 5, 2018
2011 – 2014
United States locations
- U.S. sites
- 25
- U.S. states
- 12
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 011 | Little Rock | Arkansas | 72211 | — |
| Forest Investigative Site 018 | Cerritos | California | 90703 | — |
| Forest Investigative Site 007 | Costa Mesa | California | 92626 | — |
| Forest Investigative Site 026 | Culver City | California | 90230 | — |
| Forest Investigative Site 008 | Long Beach | California | 90813 | — |
| Forest Investigative Site 002 | Oceanside | California | 92056 | — |
| Forest Investigative Site 019 | Orange | California | 92868 | — |
| Forest Investigative Site 001 | Paramount | California | 90723 | — |
| Forest Investigative Site 020 | San Diego | California | 92123 | — |
| Forest Investigative Site 005 | Washington D.C. | District of Columbia | 20016 | — |
| Forest Investigative Site 024 | Leesburg | Florida | 34748 | — |
| Forest Investigative Site 017 | Atlanta | Georgia | 30331 | — |
| Forest Investigative Site 021 | Chicago | Illinois | 60640 | — |
| Forest Investigative Site 023 | Baltimore | Maryland | 21202 | — |
| Forest Investigative Site 010 | Rockville | Maryland | 20850 | — |
| Forest Investigative Site 003 | Flowood | Mississippi | 39232 | — |
| Forest Investigative Site 006 | Creve Coeur | Missouri | 63141 | — |
| Forest Investigative Site 014 | St Louis | Missouri | 63141 | — |
| Forest Investigative Site 012 | Cedarhurst | New York | 11516 | — |
| Forest Investigative Site 022 | Dayton | Ohio | 45417 | — |
| Forest Investigative Site 015 | Austin | Texas | 78731 | — |
| Forest Investigative Site 027 | Austin | Texas | 78754 | — |
| Forest Investigative Site 025 | Dallas | Texas | 75231 | — |
| Forest Investigative Site 013 | Houston | Texas | 77008 | — |
| Forest Investigative Site 009 | Houston | Texas | 77021 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01412060, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 5, 2018 · Synced Sep 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01412060 live on ClinicalTrials.gov.